Introduced by Rep. Sue Allor (R) on February 24, 2021
To prohibit pharmacies or a pharmacists from entering a contract that forbids their telling customers the current selling price of other brand name or generic versions of a drug, or interchangeable biological drug products. The bill would also let pharmacists provide certain price information without having to be asked. Official Text and Analysis.
Referred to the House Health Policy Committee on February 24, 2021
Reported in the House on March 11, 2021
Without amendment and with the recommendation that the bill pass.